sistently translated into practice. 2 Continuing use of ineffective treatments wastes resources and harms patients. 3 There may be multiple reasons for persistence of reversed practices. Commercial entities may resist evidence of reversal that threatens profitability. 4 Academic and/or specialist biases might also contribute to persistence of reversed practices. Specialist societies strongly influence clinical practice in their specific disciplines. 5 We analyzed the responses of specialist societies to publication of evidence for medical reversal.
Methods | We identified 20 examples of medical reversal (12 medical, 5 procedural, and 3 screening) reported by 24 publications in major internal medicine journals (Table) . We searched EurekAlert!, Web of Science, and Google for responses (press releases, position statements, and clinical guidelines) of specialist societies to the publication of evidence for reversal of practice, restricting the analysis to the first response from a society on a topic. For comparison, we analyzed journal responses (editorials and clinical practice articles) published in the same issue as the source publication. Two of us (M.T.M.W. and A.G.) independently rated each response as supportive of, neutral toward, or challenging the reversed practice and recommending, neutral toward, or not recommending use of the intervention in some or all patients. Consensus to resolve differences was required for 10% of the assessments. We rated the reversed practice as being of high (n = 100), moderate (n = 44), or low (n = 12) importance to members of the responding society. Each ordinal dependent variable was modeled using Proc Genmod in SAS, version 9.4 (SAS Institute Inc) to explore differences between the sources of the responses, controlling for collinearity between responses made to the same study. Interaction terms were included in the fully saturated model to assess potential determinants of resistance.
Results | We analyzed 156 specialist society responses, with a median time since publication of the evidence for reversal of practice of 591 days (range, 2-4115 days), and 21 journal responses. Specialist society responses were more supportive of, and less likely to challenge, the reversed practice than were journal responses (supportive, 49% vs 24%; challenge, 31% vs 62%; P = .003) and were more likely to recommend the reversed practice for all or some patients (recommend, 54% vs 29%; not recommend, 31% vs 57%; P = .01) (Figure) .
Resistance to reversal of practice by specialist societies was greater when the reversed practice was assessed to be very important to its members (P < .001). No interaction was found between resistance to reversal, source of response, and either level of prior supporting evidence or type of intervention.
Discussion | Specialist societies are moderately resistant to medical reversal. The notion that "specialist bias" favors continuation of reversed practices is supported by our findings because journal responses were less resistant to changing practice and specialist societies' resistance to reversal was related to the importance of the reversed practice to members of the responding society. Publications favorably disposed toward reversed practices are predominantly found in specialty journals. 2 Journal responses may also be susceptible to bias: selection of editorial authors might favor endorsement of the reversing publication, thus reducing resistance, or editorial authors might have academic investment in the reversed practice, thus favoring resistance. Our findings might reflect inherent conservatism among physicians, but physicians were not conservative in adopting most of the reversed practices without rigorous supporting evidence (Table) . Interpretive biases favoring greater stringency in evaluating evidence that challenges established ideas, discounting of data by selective criticism of methods, and adherence to arguments of plausibility 6 b Publications in major internal medicine journals that spanned a range of disciplines, spanned a range of types of interventions, and reported large randomized trials with clinically important outcomes that superceded previously available evidence. c A total of 156 specialist society responses were analyzed, including 77 guidelines, 54 statements, 17 press releases, 5 reports, and 3 reviews.
d This number applies to both of the publications regarding use of vitamin D and calcium for the prevention of fractures; it is the number of specialist society responses to the collective evidence. e This number applies to both of the publications regarding prostate-specific antigen screening for detection of prostate cancer; it is the number of specialist society responses to the collective evidence. f This number applies to both the publications regarding vertebroplasty for treatment of painful vertebral fractures; it is the number of specialist society responses to the collective evidence.
Effect of the 2014 Atrial Fibrillation Guideline Revisions on the Proportion of Patients Recommended for Oral Anticoagulation
In 2014, the American Heart Association, American College of Cardiology, and Heart Rhythm Society published a revised guideline for atrial fibrillation (AF) treatment recommending use of a refined stroke risk score and revised threshold for oral anticoagulation (OAC) initiation. 1 We assessed the potential effect of this new guideline by comparing the proportion of patients with AF recommended for OAC under the 2011 and 2014 guidelines.
1,2
Methods | We used data from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) study, a national, prospective, outpatient registry of AF in patients 18 years or older at 176 sites in the United States. 3 The primary outcome was the proportion of patients recommended for OAC at baseline under each guideline. The CHADS 2 score, recommended for stroke risk assessment by the 2011 guideline, incorporates information on prior stroke and transient ischemic attack, congestive heart failure and dysfunction, hypertension, age of 75 years or older, and diabetes mellitus (score range, 0-6). 4 The revised 2014 guideline recommends use of the CHA 2 DS 2 -VASc score, which increases the point value from 1 to 2 for age of 75 years and older and adds elements for female sex, vascular disease, and age of 65 through 74 years (score range, 0-9). 5 We con- Figure) . For patients younger than 65 years, the proportion recommended for OAC increased from 43.1% to 60.6%, whereas the proportion recommended for patients 65 years or older increased from 79.1% to 98.5%. Among women, the percentage recommended increased from 76.7% to 97.7%. Of 1926 patients who were newly recommended for OAC, 43.6% were reclassified because of a single risk factor, 49.5% because of 2 risk factors, and 6.9% because of 3 risk factors. Female sex was a contributing factor for 46.8% of patients who were reclassified, age for 81.4%, and vascular disease for 35.1%. Among those reclassified because of a single risk factor, 20.7% were reclassified because of female sex, 63.8% because of age, and 15.5% because of vascular disease. Extrapolating under the assumption that the stroke risk distribution in ORBIT-AF is representative of that of the broader US AF population, adoption of the 2014 guideline could result in reclassification of 988 500 individuals as newly recommended for OAC (Table) . 
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